Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.185 AUD -2.63% Market Closed
Market Cap: 195.6m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Intrinsic Value

ALA doesn't have a meaningful market cap.

The intrinsic value of one ALA stock under the Base Case scenario is 0.006 AUD. Compared to the current market price of 0.185 AUD, Arovella Therapeutics Ltd is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALA Intrinsic Value
0.006 AUD
Overvaluation 97%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Arovella Therapeutics Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALA?
Bearish
Neutral
Bullish

Fundamental Analysis

Arovella Therapeutics Ltd
AU
Pharmaceuticals
Market Cap
194.4m AUD
IPO
Jan 24, 2002
Employees
-
Australia
Market Cap
194.4m AUD
Industry
Pharmaceuticals
IPO
Jan 24, 2002

Arovella Therapeutics Ltd. develops pharmaceuticals and distributes medical devices and consumables. The company is headquartered in Perth, Western Australia. The company went IPO on 2002-01-24. The firm focuses on specific disease areas, oncology and conditions that affect the central nervous system. The company is focused on developing therapies to treat human disease. The firm is developing its invariant natural killer T (iNKT) cell therapy platform to treat blood cancers. The firm's OroMist technology develops oral sprays to reformulate pharmaceuticals. Its ZolpiMist oral spray formulation of zolpidem tartrate to treat short-term insomnia. The company is also developing oral sprays to treat migraine headaches, motion sickness, and drug-resistant epilepsy.

[ Read More ]

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Arovella Therapeutics Ltd

Provide an overview of the primary business activities
of Arovella Therapeutics Ltd.

What unique competitive advantages
does Arovella Therapeutics Ltd hold over its rivals?

What risks and challenges
does Arovella Therapeutics Ltd face in the near future?

Has there been any significant insider trading activity
in Arovella Therapeutics Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Arovella Therapeutics Ltd.

Provide P/S
for Arovella Therapeutics Ltd.

Provide P/E
for Arovella Therapeutics Ltd.

Provide P/OCF
for Arovella Therapeutics Ltd.

Provide P/FCFE
for Arovella Therapeutics Ltd.

Provide P/B
for Arovella Therapeutics Ltd.

Provide EV/S
for Arovella Therapeutics Ltd.

Provide EV/GP
for Arovella Therapeutics Ltd.

Provide EV/EBITDA
for Arovella Therapeutics Ltd.

Provide EV/EBIT
for Arovella Therapeutics Ltd.

Provide EV/OCF
for Arovella Therapeutics Ltd.

Provide EV/FCFF
for Arovella Therapeutics Ltd.

Provide EV/IC
for Arovella Therapeutics Ltd.

Show me price targets
for Arovella Therapeutics Ltd made by professional analysts.

What are the Revenue projections
for Arovella Therapeutics Ltd?

How accurate were the past Revenue estimates
for Arovella Therapeutics Ltd?

What are the Net Income projections
for Arovella Therapeutics Ltd?

How accurate were the past Net Income estimates
for Arovella Therapeutics Ltd?

What are the EPS projections
for Arovella Therapeutics Ltd?

How accurate were the past EPS estimates
for Arovella Therapeutics Ltd?

What are the EBIT projections
for Arovella Therapeutics Ltd?

How accurate were the past EBIT estimates
for Arovella Therapeutics Ltd?

Compare the revenue forecasts
for Arovella Therapeutics Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Arovella Therapeutics Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Arovella Therapeutics Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Arovella Therapeutics Ltd compared to its peers.

Compare the P/E ratios
of Arovella Therapeutics Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Arovella Therapeutics Ltd with its peers.

Analyze the financial leverage
of Arovella Therapeutics Ltd compared to its main competitors.

Show all profitability ratios
for Arovella Therapeutics Ltd.

Provide ROE
for Arovella Therapeutics Ltd.

Provide ROA
for Arovella Therapeutics Ltd.

Provide ROIC
for Arovella Therapeutics Ltd.

Provide ROCE
for Arovella Therapeutics Ltd.

Provide Gross Margin
for Arovella Therapeutics Ltd.

Provide Operating Margin
for Arovella Therapeutics Ltd.

Provide Net Margin
for Arovella Therapeutics Ltd.

Provide FCF Margin
for Arovella Therapeutics Ltd.

Show all solvency ratios
for Arovella Therapeutics Ltd.

Provide D/E Ratio
for Arovella Therapeutics Ltd.

Provide D/A Ratio
for Arovella Therapeutics Ltd.

Provide Interest Coverage Ratio
for Arovella Therapeutics Ltd.

Provide Altman Z-Score Ratio
for Arovella Therapeutics Ltd.

Provide Quick Ratio
for Arovella Therapeutics Ltd.

Provide Current Ratio
for Arovella Therapeutics Ltd.

Provide Cash Ratio
for Arovella Therapeutics Ltd.

What is the historical Revenue growth
over the last 5 years for Arovella Therapeutics Ltd?

What is the historical Net Income growth
over the last 5 years for Arovella Therapeutics Ltd?

What is the current Free Cash Flow
of Arovella Therapeutics Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Arovella Therapeutics Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Arovella Therapeutics Ltd

Balance Sheet Decomposition
Arovella Therapeutics Ltd

Current Assets 13.2m
Cash & Short-Term Investments 12.7m
Other Current Assets 439.2k
Non-Current Assets 131.1k
PP&E 131.1k
Other Non-Current Assets -10
Current Liabilities 2m
Accounts Payable 1.8m
Other Current Liabilities 215.7k
Non-Current Liabilities 15.9k
Other Non-Current Liabilities 15.9k
Efficiency

Earnings Waterfall
Arovella Therapeutics Ltd

Revenue
155.7k AUD
Cost of Revenue
0 AUD
Gross Profit
155.7k AUD
Operating Expenses
-8.9m AUD
Operating Income
-8.7m AUD
Other Expenses
-8.6k AUD
Net Income
-8.7m AUD

Free Cash Flow Analysis
Arovella Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALA Profitability Score
Profitability Due Diligence

Arovella Therapeutics Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROIC
ROIC is Increasing
Negative 1-Year Revenue Growth
31/100
Profitability
Score

Arovella Therapeutics Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

ALA Solvency Score
Solvency Due Diligence

Arovella Therapeutics Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Arovella Therapeutics Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALA Price Targets Summary
Arovella Therapeutics Ltd

There are no price targets for ALA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALA?

Click here to dive deeper.

Dividends

Arovella Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ALA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one ALA stock?

The intrinsic value of one ALA stock under the Base Case scenario is 0.006 AUD.

Is ALA stock undervalued or overvalued?

Compared to the current market price of 0.185 AUD, Arovella Therapeutics Ltd is Overvalued by 97%.

Back to Top